Prediction of the risk of harboring prostate cancer by a prebiopsy nomogram based on extended biopsy protocol
Standard
Prediction of the risk of harboring prostate cancer by a prebiopsy nomogram based on extended biopsy protocol. / Nicolaiew, Nathalie; Ploussard, Guillaume; Chun, Felix K-H; Xylinas, Evanguelos; Allory, Yves; Salomon, Laurent; de la Taille, Alexandre.
in: UROL INT, Jahrgang 90, Nr. 3, 01.01.2013, S. 306-11.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Prediction of the risk of harboring prostate cancer by a prebiopsy nomogram based on extended biopsy protocol
AU - Nicolaiew, Nathalie
AU - Ploussard, Guillaume
AU - Chun, Felix K-H
AU - Xylinas, Evanguelos
AU - Allory, Yves
AU - Salomon, Laurent
AU - de la Taille, Alexandre
N1 - Copyright © 2013 S. Karger AG, Basel.
PY - 2013/1/1
Y1 - 2013/1/1
N2 - OBJECTIVE: We aimed to build a nomogram allowing to predict the probability of prostate cancer (PC) after an initial 21-core biopsy and with readily available clinical data.METHODS: 1,490 screened men who underwent an initial 21-core biopsy protocol were included. A multivariate logistic regression was realized including age, prostate volume, prostate-specific antigen (PSA) level, digital rectal examination (DRE) and transrectal ultrasonography (TRUS). Receiver-operating characteristic estimates were used to quantify accuracy of each model.RESULTS: PC was detected in 41.3% of the patients. Median PSA, age and prostate volume were 6.2 ng/ml (range 0.2-50), 64.6 years (range 33-87) and 40 ml (range 10-270), respectively. Abnormal TRUS findings were detected in 14.7% of patients. Age, PSA level, prostate volume, DRE and TRUS were significantly associated with PC (all p ≤ 0.004) in univariable logistic regression analysis. In multivariate logistic regression analysis, significant associations were found for age, PSA level, prostate volume and DRE. Predictive accuracy estimate of this model was equal to 0.70. TRUS was not an independent predictor of PC.CONCLUSIONS: We constructed the first prebiopsy predictive nomogram based on an extended 21-core biopsy procedure with age, PSA level, DRE and prostate volume which are readily available clinical data to urologists.
AB - OBJECTIVE: We aimed to build a nomogram allowing to predict the probability of prostate cancer (PC) after an initial 21-core biopsy and with readily available clinical data.METHODS: 1,490 screened men who underwent an initial 21-core biopsy protocol were included. A multivariate logistic regression was realized including age, prostate volume, prostate-specific antigen (PSA) level, digital rectal examination (DRE) and transrectal ultrasonography (TRUS). Receiver-operating characteristic estimates were used to quantify accuracy of each model.RESULTS: PC was detected in 41.3% of the patients. Median PSA, age and prostate volume were 6.2 ng/ml (range 0.2-50), 64.6 years (range 33-87) and 40 ml (range 10-270), respectively. Abnormal TRUS findings were detected in 14.7% of patients. Age, PSA level, prostate volume, DRE and TRUS were significantly associated with PC (all p ≤ 0.004) in univariable logistic regression analysis. In multivariate logistic regression analysis, significant associations were found for age, PSA level, prostate volume and DRE. Predictive accuracy estimate of this model was equal to 0.70. TRUS was not an independent predictor of PC.CONCLUSIONS: We constructed the first prebiopsy predictive nomogram based on an extended 21-core biopsy procedure with age, PSA level, DRE and prostate volume which are readily available clinical data to urologists.
KW - Adult
KW - Age Factors
KW - Aged
KW - Biopsy, Large-Core Needle
KW - Chi-Square Distribution
KW - Decision Support Techniques
KW - Digital Rectal Examination
KW - Humans
KW - Kallikreins
KW - Logistic Models
KW - Male
KW - Middle Aged
KW - Multivariate Analysis
KW - Nomograms
KW - Odds Ratio
KW - Organ Size
KW - Predictive Value of Tests
KW - Prostate-Specific Antigen
KW - Prostatic Neoplasms
KW - Risk Assessment
KW - Risk Factors
U2 - 10.1159/000345603
DO - 10.1159/000345603
M3 - SCORING: Journal article
C2 - 23295308
VL - 90
SP - 306
EP - 311
JO - UROL INT
JF - UROL INT
SN - 0042-1138
IS - 3
ER -